Mesoblast Discusses Conducting Clinical Trials at Stem Cells USA

Mesoblast uses mesenchymal precursor cells for cardiovascular and bone regeneration therapies. Their products are developed to be used ‘off the shelf’, and multiple clinical trials are being conducted simultaneously for a variety of applications. At this year’s Stem Cells USA, they discussed conducting clinical trials using these cells.

-Original content provided by an on-site blogger at the Stem Cells USA & Regenerative Medicine Congress